Navigation Links
Extra Doses of Vitamins C, E Don't Guard Against Preeclampsia
Date:11/30/2007

Study adds to evidence that supplementation during pregnancy makes little difference

FRIDAY, Nov. 30 (HealthDay News) -- Taking extra doses of vitamins E and C doesn't reduce the chances of the blood pressure disorder preeclampsia in women who are at risk for the dangerous pregnancy complication, a new report finds.

The study casts real doubt on the effectiveness of this regimen in preventing preeclampsia, said study author Dr. Joseph A. Spinnato II, a professor of obstetrics and gynecology at the University of Cincinnati College of Medicine. "There were those that were arguing that the evidence was enough prior to our publication, so I think this is added weight," he said.

There may be other avenues of hope, however.

"The article was compelling and a little disappointing, but the authors left us with an out at the end of the article, that perhaps we shouldn't give E and C at the same time because the E might negate the C," said Dr. Miriam Greene, an assistant professor of obstetrics and gynecology at New York University School of Medicine in New York City. "You can continue and try to do the two separately. They did prove that the drugs were safe."

The findings appears in the December issue of Obstetrics & Gynecology.

Preeclampsia, which occurs in about 5 percent of all pregnant women in the United States, can lead to sudden high blood pressure and irregular blood flow. This can activate platelets and the clotting system, which in turn slows blood flow further.

Risk factors for preeclampsia include: first pregnancy, 10 years since previous pregnancy, carrying multiple fetuses, being overweight, being under 20 or over 35, or having a history of high blood pressure, diabetes, kidney disease, lupus or preeclampsia in a previous pregnancy, according to the March of Dimes.

At present, medical professionals have no clear guidance on how to prevent this potentially fatal condition.

"We don't have a good way to reduce the incidence of preeclampsia, except in calcium-deficient populations and those tend not to be in the U.S.," Spinnato said. "There is some evidence that still supports the use of baby aspirin among patients at risk, but even that is argued pretty heavily."

An Australian study published last year also found no benefit to vitamin C and E supplementation.

The current study involved 707 women at four Brazilian sites who were in their second trimester of pregnancy and who had chronic hypertension or a prior history of preeclampsia.

The women were randomly assigned to receive 1,000 milligrams of vitamin C with 400 International Units of vitamin E or a placebo daily.

The rate of preeclampsia was 13.8 percent in the vitamin group and 15.6 percent in placebo group, which was not a statistically significant difference.

There appeared to be no harmful effects on the fetus, a finding echoed in previous trials.

But this study had one surprise finding: more frequent premature rupture of membranes among women taking vitamins. "That was completely unexpected," said Spinnato, who is following up on the finding.

Other than the possibility that vitamin E is canceling out vitamin C, there is no clear explanation for why the combination didn't work.

"One of the continuing challenges to vitamin supplementation as a general thing is getting it from leafy vegetables is different than getting it from a pill," Spinnato said. "There are also those who argue that we didn't start [giving the vitamins] early enough, but that argument is difficult to swallow. There are medical and legal ramifications even for vitamins."

More information

To learn more about preeclampsia, visit the March of Dimes.



SOURCES: Joseph A. Spinnato II, M.D., professor, obstetrics and gynecology, University of Cincinnati College of Medicine; Miriam Greene, M.D., assistant professor, obstetrics and gynecology, New York University School of Medicine, New York City; December 2007 Obstetrics & Gynecology


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New study: Pine bark extract reduces ADHD symptoms in children
2. IMA South American Extravaganza Dinner to Honor Coachella Valley Doctor
3. MassMutual Agent Honored by Insurance Industry for Extraordinary Service to Client
4. Wrigleys Orbit(R), Extra(R) and Eclipse(R) Sugar-Free Chewing Gums Awarded American Dental Associations Seal of Acceptance
5. NBME Appeals Massachusetts Judges Reversal of Lower Court in Suit for Extra Break Time During Medical Licensing Exam
6. Missouri House Recognizes Extraordinary Efforts Supporting National Guard Families
7. Portal vein thrombosis is common in extraportal vein obstruction
8. New study: pine bark extract boosts nitric oxide production
9. Markel Expands Classes for Contagion Risk with OUTBREAK(R) Extra Expense Coverage
10. Broccoli sprout-derived extract protects against ultraviolet radiation
11. Extracts of catfish caught in polluted waters cause breast cancer cells to multiply
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Extra Doses of Vitamins C, E Don't Guard Against Preeclampsia
(Date:4/28/2017)... New York, NY (PRWEB) , ... April 28, ... ... Shiel Medical Laboratory to expanded distribution of the GlycoMark test throughout the Northeast ... indicates recent hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly ... offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and ... These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back Surgery and ... revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified Anesthesiologist, with ... revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike traditional back ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The Texas ... in recently to the labor and delivery team at Women’s Hospital at Renaissance in ... who give birth at the hospital and decide to donate. , “Women’s Hospital ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... hERG liability could substantially improve drug safety and minimize the cost of development. ... validating ion channel inhibition using cell lines and for cardiac toxicity using induced ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
Breaking Medicine Technology: